ConductScience.org, home

Paper11936701

Estimating the starting dose for entry into humans: principles and practice.

Reigner BG and 1 other. Eur J Clin Pharmacol, 2002. Cited by 89 papers, by iCite.

Cite this record

ConductScience Library. Estimating the starting dose for entry into humans: principles and practice. Papers, record 11936701. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11936701

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Estimating the starting dose for entry into humans: principles and practice.
PubMed
Journal
Eur J Clin Pharmacol
PubMed
Year
2002
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
89
iCite
Relative citation ratio, by iCite
2.43
iCite
Revised in PubMed
2019-08-13
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Reigner BGBruno G
2Blesch KSKaren Smith

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Pharmaceutical PreparationsMajor topic
PharmacokineticsMajor topic
Animals
Antineoplastic Agents
Drug Industry
Humans
Maximum Tolerated Dose
No-Observed-Adverse-Effect Level

Source PubMed

Download CSV of topics

Cited by45

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 89 citations.

PMIDTitleJournalYearIn PapersSource
42682178Physiologically Based Pharmacokinetic Modeling to Predict Human Starting Dose and Pharmacokinetics for Rocbrutinib.Clin Transl Sci2026https://conductscience.org/library/papers/42682178PubMed
42666965Risk Management in First-in-Human Trials of Intravenous Drugs: Current Practices and Future Perspectives.Ther Clin Risk Manag2026https://conductscience.org/library/papers/42666965PubMed
42514940First-in-Human Dose Selection, Pharmacokinetics Prediction, and Clinical Validation of SYHA1805, a Novel FXR Agonist, Using Allometric Scaling and PBPK Modeling.Pharmaceutics2026https://conductscience.org/library/papers/42514940PubMed
42500957Comparative validation of LC-MS, micro-bioassay, and ELISA for lincomycin quantification: application to pharmacokinetic analysis in healthy and co-infected porcine models.Vet Q2026https://conductscience.org/library/papers/42500957PubMed
42418317Predicting First-in-Human Pharmacokinetics: Comparative Evaluation of Standard PBPK, High-Throughput PBPK, and Machine Learning.Mol Pharm2026https://conductscience.org/library/papers/42418317PubMed
41898218Intranasal Drug Delivery in Neuropharmacology: Advances in Brain-Targeted Therapies and Bioethical Challenges.Biomedicines2026https://conductscience.org/library/papers/41898218PubMed
40760081The Parkinson's drug benztropine possesses histamine receptor 1-dependent host-directed antimicrobial activity against Mycobacterium tuberculosis.NPJ Antimicrob Resist2025https://conductscience.org/library/papers/40760081PubMed
39833376Effects of psychedelics on opioid use disorder: a scoping review of preclinical studies.Cell Mol Life Sci2025https://conductscience.org/library/papers/39833376PubMed
39304595Prediction of First-in-Human Dose of Chimeric Antigen Receptor-T (CAR-T) Cells from Mice.Eur J Drug Metab Pharmacokinet2024https://conductscience.org/library/papers/39304595PubMed
39280932Effects of maternal nonylphenol exposure on the proliferation of glial cells in the brain of male offspring mice.Anim Cells Syst (Seoul)2024https://conductscience.org/library/papers/39280932PubMed
38251163
Neuroprotective Effect of Solid Lipid Nanoparticles Loaded with Lepidium sativum (L.) Seed Bioactive Components Enhance Bioavailability and Wnt/β-Catenin/Camk-II Signaling Cascade in SH-SY5Y Neuroblastoma Cells.
Nanomaterials (Basel)2024https://conductscience.org/library/papers/38251163PubMed
38126024Mathematical modeling of cancer immunotherapy for personalized clinical translation.Nat Comput Sci2022https://conductscience.org/library/papers/38126024PubMed
35688844Testicular ultrastructure and hormonal changes following administration of tenofovir disoproxil fumarate-loaded silver nanoparticle in type-2 diabetic rats.Sci Rep2022https://conductscience.org/library/papers/35688844PubMed
35592432Rapamycin in Cerebral Cavernous Malformations: What Doses to Test in Mice and Humans.ACS Pharmacol Transl Sci2022https://conductscience.org/library/papers/35592432PubMed
35382850Propranolol as therapy for cerebral cavernous malformations: a cautionary note.J Transl Med2022https://conductscience.org/library/papers/35382850PubMed
34917828Highly active antiretroviral therapy conjugated silver nanoparticle ameliorates testicular injury in type-2 diabetic rats.Heliyon2021https://conductscience.org/library/papers/34917828PubMed
34849651Randomized Trial of Metformin With Anti-Tuberculosis Drugs for Early Sputum Conversion in Adults With Pulmonary Tuberculosis.Clin Infect Dis2022https://conductscience.org/library/papers/34849651PubMed
34562983A Single Animal Species-Based Prediction of Human Clearance and First-in-Human Dose of Monoclonal Antibodies: Beyond Monkey.Antibodies (Basel)2021https://conductscience.org/library/papers/34562983PubMed
34120326Comparison of Various Approaches to Translate Non-Linear Pharmacokinetics of Monoclonal Antibodies from Cynomolgus Monkey to Human.Eur J Drug Metab Pharmacokinet2021https://conductscience.org/library/papers/34120326PubMed
33922017The Use of Translational Modelling and Simulation to Develop Immunomodulatory Therapy as an Adjunct to Antibiotic Treatment in the Context of Pneumonia.Pharmaceutics2021https://conductscience.org/library/papers/33922017PubMed

See all 45 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/11936701

GET https://conductscience.org/api/papers/v1/11936701/cited_by?page=2